{"id":29377,"date":"2020-07-17T06:28:06","date_gmt":"2020-07-17T06:28:06","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=29377"},"modified":"2020-07-17T06:28:06","modified_gmt":"2020-07-17T06:28:06","slug":"serotonin-norepinephrine-reuptake-inhibitors-snris","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/","title":{"rendered":"Serotonin-norepinephrine reuptake inhibitors (SNRIs)"},"content":{"rendered":"<p>A class of atypical antidepressants that exert their action by inhibiting presynaptic reuptake of the neurotransmitters serotonin and norepinephrine. They are used for the treatment of depression and anxiety disorders as well as in pain management of diabetic peripheral neuropathy and fibromyalgia. Examples of SNRIs include duloxetine (cymbalta), desvenlafaxine (prestiq), and venlafaxine (effexor).<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A class of atypical antidepressants that exert their action by inhibiting presynaptic reuptake of the neurotransmitters serotonin and norepinephrine. They are used for the treatment of depression and anxiety disorders as well as in pain management of diabetic peripheral neuropathy and fibromyalgia. Examples of SNRIs include duloxetine (cymbalta), desvenlafaxine (prestiq), and venlafaxine (effexor). &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-29377","post","type-post","status-publish","format-standard","hentry","category-s"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Serotonin-norepinephrine reuptake inhibitors (SNRIs) - Definition of Serotonin-norepinephrine reuptake inhibitors (SNRIs)<\/title>\n<meta name=\"description\" content=\"A class of atypical antidepressants that exert their action by inhibiting presynaptic reuptake of the neurotransmitters serotonin and norepinephrine. They are used for the treatment of depression and anxiety disorders as well as in pain management of diabetic peripheral neuropathy and fibromyalgia. Examples of SNRIs include duloxetine (cymbalta), desvenlafaxine (prestiq), and venlafaxine (effexor).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Serotonin-norepinephrine reuptake inhibitors (SNRIs) - Definition of Serotonin-norepinephrine reuptake inhibitors (SNRIs)\" \/>\n<meta property=\"og:description\" content=\"A class of atypical antidepressants that exert their action by inhibiting presynaptic reuptake of the neurotransmitters serotonin and norepinephrine. They are used for the treatment of depression and anxiety disorders as well as in pain management of diabetic peripheral neuropathy and fibromyalgia. Examples of SNRIs include duloxetine (cymbalta), desvenlafaxine (prestiq), and venlafaxine (effexor).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-17T06:28:06+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/\",\"name\":\"Serotonin-norepinephrine reuptake inhibitors (SNRIs) - Definition of Serotonin-norepinephrine reuptake inhibitors (SNRIs)\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-17T06:28:06+00:00\",\"dateModified\":\"2020-07-17T06:28:06+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A class of atypical antidepressants that exert their action by inhibiting presynaptic reuptake of the neurotransmitters serotonin and norepinephrine. They are used for the treatment of depression and anxiety disorders as well as in pain management of diabetic peripheral neuropathy and fibromyalgia. Examples of SNRIs include duloxetine (cymbalta), desvenlafaxine (prestiq), and venlafaxine (effexor).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Serotonin-norepinephrine reuptake inhibitors (SNRIs)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Serotonin-norepinephrine reuptake inhibitors (SNRIs) - Definition of Serotonin-norepinephrine reuptake inhibitors (SNRIs)","description":"A class of atypical antidepressants that exert their action by inhibiting presynaptic reuptake of the neurotransmitters serotonin and norepinephrine. They are used for the treatment of depression and anxiety disorders as well as in pain management of diabetic peripheral neuropathy and fibromyalgia. Examples of SNRIs include duloxetine (cymbalta), desvenlafaxine (prestiq), and venlafaxine (effexor).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/","og_locale":"en_US","og_type":"article","og_title":"Serotonin-norepinephrine reuptake inhibitors (SNRIs) - Definition of Serotonin-norepinephrine reuptake inhibitors (SNRIs)","og_description":"A class of atypical antidepressants that exert their action by inhibiting presynaptic reuptake of the neurotransmitters serotonin and norepinephrine. They are used for the treatment of depression and anxiety disorders as well as in pain management of diabetic peripheral neuropathy and fibromyalgia. Examples of SNRIs include duloxetine (cymbalta), desvenlafaxine (prestiq), and venlafaxine (effexor).","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/","og_site_name":"Glossary","article_published_time":"2020-07-17T06:28:06+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/","name":"Serotonin-norepinephrine reuptake inhibitors (SNRIs) - Definition of Serotonin-norepinephrine reuptake inhibitors (SNRIs)","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-17T06:28:06+00:00","dateModified":"2020-07-17T06:28:06+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A class of atypical antidepressants that exert their action by inhibiting presynaptic reuptake of the neurotransmitters serotonin and norepinephrine. They are used for the treatment of depression and anxiety disorders as well as in pain management of diabetic peripheral neuropathy and fibromyalgia. Examples of SNRIs include duloxetine (cymbalta), desvenlafaxine (prestiq), and venlafaxine (effexor).","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/serotonin-norepinephrine-reuptake-inhibitors-snris\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Serotonin-norepinephrine reuptake inhibitors (SNRIs)"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=29377"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29377\/revisions"}],"predecessor-version":[{"id":29378,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29377\/revisions\/29378"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=29377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=29377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=29377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}